Persistent Asset Partners’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
Other funds holding RLAY
Persistent Asset Partners's RLAY Position: Q3 2026 in Review
Persistent Asset Partners sold out of Relay Therapeutics (RLAY) in Q3 2026, closing a stake of 70,693 shares — an estimated $1.32M sold.
Persistent Asset Partners first reported a position in RLAY in Q4 2024 and held it in 6 quarters. The position peaked at $1.32M in Q2 2026. 261 funds tracked by Wall St. Rank hold RLAY as of Q3 2026.
- Persistent Asset Partners reported no remaining Relay Therapeutics position as of Q3 2026 after selling out during the quarter.
- Persistent Asset Partners sold 70,693 Relay Therapeutics shares in Q3 2026, an estimated $1.32M.
- Persistent Asset Partners first reported a position in Relay Therapeutics in Q4 2024 and held it in 6 quarters.
- Persistent Asset Partners's Relay Therapeutics position peaked at $1.32M in Q2 2026.
- 261 funds tracked by Wall St. Rank held Relay Therapeutics as of Q3 2026.
Based on Persistent Asset Partners's 13F filing for Q3 2026, filed 13 Nov 2026.